{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,12]],"date-time":"2023-11-12T00:31:31Z","timestamp":1699749091082},"reference-count":17,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2008,3,17]],"date-time":"2008-03-17T00:00:00Z","timestamp":1205712000000},"content-version":"vor","delay-in-days":9329,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[1982,9]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>To determine the adrenal contribution to plasma concentrations of steroids potentially derived from both the adrenal and the testes, plasma levels of pregnenolone (\u0394<jats:sup>5<\/jats:sup>P), progesterone (P), dehydroepiandrosterone and its sulphate (DHA and DHAS) and androstenedione (\u0394<jats:sup>4<\/jats:sup>A) were measured in four men with isolated gonadotrophin deficiency and anosmia (Kallman's syndrome). A comparison of these levels with those seen in ten patients with both adrenal and testicular failure (hypopituitarism) and in sixteen normal age\u2010matched men was made.<\/jats:p><jats:p>As expected, the basal plasma levels of most steroids were low in patients with hypopituitarism. An exception was the normal \u0394<jats:sup>5<\/jats:sup>P levels in most patients. In the patients with Kallman's syndrome both DHA and \u0394<jats:sup>5<\/jats:sup>P were elevated whereas \u0394<jats:sup>4<\/jats:sup>A and P were low.<\/jats:p><jats:p>When expressed as ratios, \u0394<jats:sup>5<\/jats:sup>P\/P was increased in both groups. DHA\/\u0394<jats:sup>4<\/jats:sup>A was increased in Kallman's syndrome but not in hypopituitarism. Following ACTH infusion, no significant changes in these ratios were observed.<\/jats:p><jats:p>To determine whether testosterone deficiency was in part responsible for the abnormal \u0394<jats:sup>5<\/jats:sup>\/\u0394<jats:sup>4<\/jats:sup> ratios, three patients with hypopituitarism and two with Kallman's syndrome were treated for 3 months with intramuscular testosterone. A decrease in the DHA\/\u0394<jats:sup>4<\/jats:sup>A ratio was seen in all patients and a decrease in \u0394<jats:sup>5<\/jats:sup>P\/P in all but one patient. In most cases these changes were produced by a fall in the \u0394<jats:sup>5<\/jats:sup> steroids as well as an increase in \u0394<jats:sup>4<\/jats:sup> steroids.<\/jats:p><jats:p>These findings suggest that a defect in the metabolism of \u0394<jats:sup>5<\/jats:sup> steroids exists in patients with hypopituitarism and Kallman's syndrome. In hypopituitarism the defect involves the metabolism of \u0394<jats:sup>5<\/jats:sup>P to both DHA and P. In Kallman's syndrome only the metabolism of \u0394<jats:sup>5<\/jats:sup>P to P is defective. Testosterone therapy alone or in combination with other appropriate hormonal replacement increases the metabolism of \u0394<jats:sup>5<\/jats:sup> to \u0394<jats:sup>4<\/jats:sup> steroids.<\/jats:p>","DOI":"10.1111\/j.1365-2265.1982.tb01584.x","type":"journal-article","created":{"date-parts":[[2008,3,17]],"date-time":"2008-03-17T12:55:55Z","timestamp":1205758555000},"page":"223-231","source":"Crossref","is-referenced-by-count":2,"title":["PLASMA STEROID CONCENTRATIONS IN PATIENTS WITH HYPOPITUITARISM AND KALLMAN'S SYNDROME: EFFECTS OF TESTOSTERONE REPLACEMENT THERAPY"],"prefix":"10.1111","volume":"17","author":[{"given":"J.","family":"SAGEL","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. H.","family":"LEVINE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. S.","family":"MATHUR","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"ROSEBROCK","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"GONZALEZ","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. DE","family":"VILLIER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. M. G.","family":"NAIR","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,3,17]]},"reference":[{"key":"e_1_2_1_2_1","first-page":"197","volume-title":"Regulatory Mechanisms Affecting Gonadal Hormone Action. Advances in Sex Hormone Research","author":"Andrews R.V.","year":"1977"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1210\/endo-91-5-1247"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(77)80912-8"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-49-4-604"},{"key":"e_1_2_1_6_1","volume-title":"Biostatistics: A Foundation for the Analysis in the Health Sciences.","author":"Daniel W.W.","year":"1974"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi00685a009"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI105344"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-32-1-59"},{"key":"e_1_2_1_10_1","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0021-9258(19)43115-3","article-title":"The mechanism of action of adrenocorticotropic hormone. The role of mitochondrial cholesterol accumulation in the regulation of steroidogenesis","volume":"249","author":"Mahaffee D.","year":"1974","journal-title":"Journal of Biological Chemistry"},{"key":"e_1_2_1_11_1","first-page":"21","volume-title":"Hypothalamic Hormones\u2014Chemistry, Physiology and Clinical Applications.","author":"Mathur R.S.","year":"1979"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1210\/edrv-1-4-392"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1210\/endo-103-4-1103"},{"key":"e_1_2_1_14_1","first-page":"300A","article-title":"Plasma steroid profile in Kallman's syndrome","volume":"25","author":"Rosebrock G.","year":"1977","journal-title":"Clinical Research"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-49-5-753"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.1978.02120330069017"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-41-5-894"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-4731(75)90155-7"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2265.1982.tb01584.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2265.1982.tb01584.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T16:45:10Z","timestamp":1699721110000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2265.1982.tb01584.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1982,9]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1982,9]]}},"alternative-id":["10.1111\/j.1365-2265.1982.tb01584.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2265.1982.tb01584.x","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[1982,9]]}}}